Bioventus Inc
NASDAQ:BVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bioventus Inc
NASDAQ:BVS
|
US |
|
S
|
Starbucks Corp
F:SRB
|
US |
|
Compagnie Generale des Etablissements Michelin SCA
PAR:ML
|
FR |
|
P
|
Planet Fitness Inc
F:3PL
|
US |
|
Euronet Worldwide Inc
NASDAQ:EEFT
|
US |
|
Digipath Inc
OTC:DIGP
|
US |
|
Peet Ltd
ASX:PPC
|
AU |
|
N
|
Northrop Grumman Corp
XMUN:NTH
|
US |
|
M
|
Morixe Hermanos SACI
BCBA:MORI
|
AR |
|
Rotork PLC
LSE:ROR
|
UK |
|
Alpha HPA Ltd
ASX:A4N
|
AU |
|
A
|
Air Canada
F:ADH2
|
CA |
Wall St Price Targets
BVS Price Targets Summary
Bioventus Inc
According to Wall Street analysts, the average 1-year price target for BVS is 15.1 USD with a low forecast of 14.14 USD and a high forecast of 16.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BVS's stock price target?
Price Target
15.1
USD
According to Wall Street analysts, the average 1-year price target for BVS is 15.1 USD with a low forecast of 14.14 USD and a high forecast of 16.8 USD.
What is the Revenue forecast for Bioventus Inc?
Projected CAGR
7%
Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Bioventus Inc?
Projected CAGR
25%
The compound annual growth rate for Operating Income over the next 3 years is 25%.
What is the Net Income forecast for Bioventus Inc?
Projected CAGR
30%
The compound annual growth rate for Net Income over the next 5 years is 30%.
